Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury

Victims of trauma often develop impaired blood clot formation (coagulopathy) that contributes to bleeding and mortality. Fibrin polymerization is one critical component of clot formation that can be impacted by post-translational oxidative modifications of fibrinogen after exposure to oxidants. In v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Free radical biology & medicine 2016-07, Vol.96, p.181-189
Hauptverfasser: White, Nathan J., Wang, Yi, Fu, Xiaoyun, Cardenas, Jessica C., Martin, Erika J., Brophy, Donald F., Wade, Charles E., Wang, Xu, St. John, Alexander E., Lim, Esther B., Stern, Susan A., Ward, Kevin R., López, José A., Chung, Dominic
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Victims of trauma often develop impaired blood clot formation (coagulopathy) that contributes to bleeding and mortality. Fibrin polymerization is one critical component of clot formation that can be impacted by post-translational oxidative modifications of fibrinogen after exposure to oxidants. In vitro evidence suggests that Aα-C domain methionine sulfoxide formation, in particular, can induce conformational changes that prevent lateral aggregation of fibrin protofibrils during polymerization. We used mass spectrometry of plasma from trauma patients to find that fibrinogen Aα-C domain methionine sulfoxide content was selectively-increased in patients with coagulopathy vs. those without coagulopathy. This evidence supports a novel linkage between oxidative stress, coagulopathy, and bleeding after injury. [Display omitted] •Fibrinogen methionine sulfoxide is increased in coagulopathic trauma patients.•Methionine sulfoxide is preferentially formed in the fibrinogen Aα-C domain.•Oxidation by inflammation may modulate blood coagulation responses to injury.
ISSN:0891-5849
1873-4596
DOI:10.1016/j.freeradbiomed.2016.04.023